Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma.

@article{Mrtenson2001SerumSP,
  title={Serum S-100b protein as a prognostic marker in malignant cutaneous melanoma.},
  author={E. Djureen M{\aa}rtenson and Lars O. Hansson and Bo Nilsson and Eva von Schoultz and E M{\aa}nsson Brahme and Ulrik Ringborg and Johan Hansson},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2001},
  volume={19 3},
  pages={
          824-31
        }
}
PURPOSE To evaluate whether S-100B protein in serum is an independent prognostic marker in malignant melanoma. MATERIALS AND METHODS S-100B protein in serum was analyzed in 1,007 consecutive patients with histologically verified cutaneous malignant melanoma. At the time of blood sampling, 876 patients were in clinical stage I, 35 were in stage II, and 96 were in stage III. The serum concentrations of S-100B protein were measured by a luminescence immunoassay (LIA). RESULTS The mean serum… CONTINUE READING
BETA

From This Paper

Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-10 OF 31 CITATIONS

Similar Papers

Loading similar papers…